FDA Approves Takeda’s Eohilia As First Oral Treatment For Inflammed Esophagus
Eohilia: FDA-approved oral therapy for EoE. Takeda's innovative 2mg/10mL stick packs available by February. Histologic remission achieved in studies.
Novo Nordisk’s Weight Loss Drugs Ozempic, Wegovy Show Promise For Diabetic Patients Undergoing Hip Replacement
Findings on diabetes and weight loss drugs in hip replacement. Novo Nordisk's Ozempic shows a 44% reduction in joint infections, and Wegovy proves safe, reducing complications.
‘FDA Grants Priority Review Of MDMA-Assisted Therapy For PTSD, Psychedelics Drug Development Company Says’ – Marijuana Moment
https://www.marijuanamoment.net/fda-grants-priority-review-of-mdma-assisted-therapy-for-ptsd-psychedelics-drug-development-company-says/ The Food and Drug Administration (FDA) has agreed to review
Why Is Inherited Rare Disease Focused-Larimar Therapeutics Stock Trading Lower Today?
Explore Larimar Therapeutics' 2 study on nomlabofusp for Friedreich's ataxia. Topline data, increased FXN levels, and FDA discussions for accelerated approval.
FDA Advisors Set To Discuss Abbott’s TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom
FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document.
Drugmaker Gilead Sciences Scoops Up Liver-Disease Focused CymaBay Therapeutics For $4.3B
Gilead Sciences will acquire CymaBay Therapeutics for $4.3 billion, advancing liver disease treatment with seladelpar. FDA priority review was granted, and there is potential for significant revenue growth.
Why Is Infectious Disease-Focused AN2 Therapeutics Stock Sinking Today?
AN2 Therapeutics pauses Phase 3 enrollment for epetraborole trial in Mycobacterium Avium Complex lung disease. Updates expected in summer 2024.
Novo Nordisk, Eli Lilly Stride To Boost Supply Shortage For Newly Found Holy Grail Of Miraculous Weight Loss Drugs
Challenges and updates in the weight loss drug market, as Novo Nordisk and Eli Lilly address supply shortages for Wegovy and Mounjaro. Strategies to meet the increasing demand and potential market projections.
Monogram Orthopaedics To Present Rescheduled Product Discussion With Surgeon Reaction During AAOS Annual Meeting
Event features Monogram's mBôs commercial robot alongside panel of orthopaedic surgeonsAUSTIN, TX / ACCESSWIRE / February 12, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical
Jaguar Health Announces Submission Of Orphan Drug Designation Application To The FDA For Crofelemer For Cholera-Related Diarrhea
Cholera is an acute diarrheal illness caused by infection of the intestine with the bacterium Vibrio choleraeCrofelemer previously granted Orphan Drug Designation by the FDA and the EMA for both short bowel syndrome and